Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $9.50 Average Price Target from Analysts
Shares of Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) have been given a consensus rating of “Buy” by the six analysts that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price target […]
Shares of Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) have been given a consensus rating of “Buy” by the six analysts that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price target […]
